Zürich15°Showers
Filtered by Topic
Latest patient safety news and updates from Switzerland. AI-curated articles covering patient safety topics.
← Show All NewsNovartis
Novartis has suspended several experimental CAR-T cell therapy trials after three patients died from a rare, potentially fatal immune complication. The decision raises fresh questions about the risks and oversight of next-generation treatments for autoimmune disease.
15 days ago · 1 source
Novartis
Novartis has halted several experimental CAR-T cell-therapy trials after three patients died from immune-related complications. The article should explain what rap-cel is, why the trials were suspended, the known risks of CAR-T treatments and what the decision means for patients and the wider Swiss pharmaceutical sector.
SWI swissinfo.ch
